Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
ofatumumab 100 mg, 1000 mg / vial
Locations
7
Japan
GSK Investigational Site
Aichi, Japan
GSK Investigational Site
Kanagawa, Japan
GSK Investigational Site
Nagasaki, Japan
GSK Investigational Site
Tokyo, Japan
GSK Investigational Site
Tokyo, Japan
GSK Investigational Site
Seoul, South Korea
Start Date
September 1, 2009
Primary Completion Date
April 1, 2011
Completion Date
April 1, 2011
Last Updated
May 30, 2017
NCT00824265
NCT00742144
NCT01563055
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions